Log In
Print this Print this

Grafeel, Biosimilar filgrastim

  Manage Alerts
Collapse Summary General Information
Company Dr. Reddy's Laboratories Ltd.
DescriptionBiosimilar version of filgrastim
Molecular Target Granulocyte colony-stimulating factor (G-CSF) (CSF3)
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationAnemia
Indication DetailsTreat chemotherapy induced neutropenia; Treat leukopenia associated with myelosuppressive therapies
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today